Head to head
Warby Parker vs Intuitive Surgical
Side-by-side on the measures that matter, with a plain-English read. Full detail: WRBY · ISRG
WRBY
Warby Parker
23.12-4.19%
1-year price shape — +36% over the period
Quant Rating D · 81/100
vs
ISRG
Intuitive Surgical
399.05-2.01%
1-year price shape — -28% over the period
Quant Rating D · 15/100
1-year performance, rebased to 100
Intuitive Surgical edges it on the scoreable measures. Intuitive Surgical trades cheapest on trailing earnings; Intuitive Surgical earns the most per share.
| WRBY | ISRG | |
|---|---|---|
| Snapshot | ||
| Sector | Medical Instruments & Supplies | -- |
| Last price | 23.12 | 399.05 |
| Change today | -4.19% | -2.01% |
| 1-year return | +35.9% | -27.7% |
| Market cap | $2.87B | $138.33B |
| 52-week range | 17.83 – 31.75 | 328.57 – 603.88 |
| Valuation | ||
| P/E (TTM) | 385.33 | 48.25 |
| P/E percentile, own 5-yr range | 90th | 16th |
| P/B | 7.12 | 8.65 |
| Dividend yield | 0.00% | 0.00% |
| Profitability & growth | ||
| EPS (TTM) | 0.01 | 7.87 |
| Net profit (TTM) | $1.24M | $2.73B |
| Revenue (TTM) | $934.66M | $11.58B |
| Provider revenue period date | 2026-09-29 | 2026-09-29 |
| Revenue growth (YoY) | +10.4% | +21.7% |
| Gross margin | 54.7% | 67.2% |
| Operating margin | 0.2% | 32.3% |
| Net margin | 0.8% | 25.5% |
| Free cash flow (TTM) | $21.29M | $3.60B |
| Provider cash-flow period date | 2026-09-29 | 2026-09-29 |
| Ownership & sentiment | ||
| Institutional ownership | 102.8% | 86.7% |
| Insider activity (12mo) | 17 buy / 33 sell | 17 buy / 33 sell |
| Short interest (% of float) | 16.2% | 2.0% |
| Analyst consensus | 71% buy / 29% hold (7) | 100% buy (18) |
| Analyst price target | $33 (+42%) | $516 (+29%) |
| StockVane view | ||
| StockVane Quant Rating | D (81) | D (15) |
| Company | ||
| Employees | 4,036 | 17,021 |
| Founded | 2010 | 1995 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.